Fermenta Biotech to host one-to-one investor meeting in Mumbai on July 29

Fermenta Biotech Limited will host a one-to-one physical meeting with investors in Mumbai on July 29, 2026. The interaction is part of the company’s ongoing corporate relations activities, aimed at engaging with stakeholders through direct dialogue. The company emphasized that the discussion will rely solely on existing public disclosures, ensuring compliance with regulatory norms regarding information symmetry.

The meeting was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Varadvinayak Khambete, Company Secretary & Head – Legal, signed the intimation submitted to BSE Limited on July 24, 2026. The filing confirms that no unpublished price-sensitive information (UPSI) will be discussed during the session.

Meeting Details

The specific parameters of the investor interaction are outlined below:

Date	Type of Meeting	Mode	Location
July 29, 2026	One-to-one meeting	Physical	Mumbai

According to the disclosure, the materials proposed for discussion include press releases and investor presentations already available on the company’s website and the BSE Limited portal. The company noted that changes to the schedule may occur due to exigencies on the part of either the company or the investors.

Regulatory Compliance

The intimation serves as a formal record of the planned engagement under SEBI’s disclosure framework. By pre-emptively stating that UPSI will not be shared, Fermenta Biotech aligns with market fairness principles, preventing potential insider trading concerns associated with selective disclosures. The meeting represents a routine component of investor relations strategy, allowing management to address queries based on established public data rather than forward-looking non-public insights.

What This Means for Investors

For shareholders and prospective investors, the meeting offers an opportunity for direct engagement with company officials. However, participants should expect the conversation to remain within the bounds of already published financial and operational data. The absence of new material announcements suggests the session is intended for relationship maintenance and clarification of existing strategies rather than the release of new strategic pivots or financial updates. Investors seeking updated metrics should refer to the latest quarterly results or annual reports available on the exchange websites.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+7.74%	-5.96%	+21.94%	+35.69%	+35.69%	+35.69%

Fermenta Biotech Limited has scheduled its 74th Annual General Meeting (AGM) for August 11, 2026, to transact business including the adoption of financial statements for the year ended March 31, 2026. The Board of Directors has recommended a final dividend of ₹3.75 per equity share, amounting to 75% of the face value of ₹5 each, subject to shareholder approval. The meeting will be held through Video Conferencing and Other Audio-Visual Means (VC/OAVM) at 3:00 p.m. IST.

The dividend, if approved, will be paid to members whose names appear in the Register of Members as on the record date of Wednesday, August 05, 2026. Payments are scheduled to be made on or before Friday, August 21, 2026, via electronic transfer. The company has notified shareholders that dividend amounts remaining unpaid or unclaimed for seven consecutive years will be transferred to the Investor Education and Protection Fund (IEPF).

Special Business Agenda

Shareholders will consider the re-appointment of Ms. Rajeshwari Datla as a Non-Executive Director. Ms. Datla, who is 76 years old, retires by rotation at this meeting and is eligible for re-appointment. Pursuant to SEBI regulations, her continuation beyond the age of 75 requires approval via a special resolution. She has been associated with the company since 2005 and currently serves on the Nomination and Remuneration Committee and the Corporate Social Responsibility Committee.

The AGM will also seek ratification for the remuneration of the Cost Auditor. The Board has proposed paying ₹2,75,000 plus applicable taxes and out-of-pocket expenses to M/s Joshi Apte & Associates, Cost Accountants, for conducting the cost audit for the financial year ending March 31, 2027.

Related Party Transactions

A special resolution will be put to vote regarding material related party transactions with Fermenta USA LLC (FUSA), a step-down subsidiary of the company. Shareholders are being asked to approve entering into transactions with FUSA for the sale of products up to an aggregate value of ₹100 crore. The approval is valid until the date of the next AGM in 2027. In the previous financial year (2025-2026), transactions with FUSA amounted to ₹21,75,60,039.06.

Financial Metric (FY 2025-2026)	Amount (INR)
Turnover	45,23,76,824
Profit After Tax	(2,65,30,000)
Net Worth	(12,59,80,000)

Additionally, the company seeks approval to pay commission to Non-Executive Directors, including Independent Directors, up to 1% of the net profits for the financial year 2025-26. This commission is proposed to be in addition to sitting fees and meeting expense reimbursements.

Voting and Participation

Remote e-voting will commence on Saturday, August 08, 2026, at 9:00 a.m. IST and conclude on Monday, August 10, 2026, at 5:00 p.m. IST. Members holding shares as on the record date of August 05, 2026, are eligible to vote. Mr. V. N. Deodhar, Proprietor of V. N. Deodhar & Co., has been appointed as the Scrutinizer for the voting process.